238 related articles for article (PubMed ID: 19222785)
21. CXCR3-/- mice mount an efficient Th1 response but fail to control Leishmania major infection.
Rosas LE; Barbi J; Lu B; Fujiwara Y; Gerard C; Sanders VM; Satoskar AR
Eur J Immunol; 2005 Feb; 35(2):515-23. PubMed ID: 15668916
[TBL] [Abstract][Full Text] [Related]
22. T helper differentiation in resistant and susceptible B7-deficient mice infected with Leishmania major.
Brown JA; Greenwald RJ; Scott S; Schweitzer AN; Satoskar AR; Chung C; Schopf LR; van der Woude D; Sypek JP; Sharpe AH
Eur J Immunol; 2002 Jun; 32(6):1764-72. PubMed ID: 12115660
[TBL] [Abstract][Full Text] [Related]
23. The role of mannose receptor during experimental leishmaniasis.
Akilov OE; Kasuboski RE; Carter CR; McDowell MA
J Leukoc Biol; 2007 May; 81(5):1188-96. PubMed ID: 17261547
[TBL] [Abstract][Full Text] [Related]
24. The involvement of neutrophils in the resistance to Leishmania major infection in susceptible but not in resistant mice.
Chen L; Zhang ZH; Watanabe T; Yamashita T; Kobayakawa T; Kaneko A; Fujiwara H; Sendo F
Parasitol Int; 2005 Jun; 54(2):109-18. PubMed ID: 15866472
[TBL] [Abstract][Full Text] [Related]
25. Mast cells at the host-pathogen interface: host-protection versus immune evasion in leishmaniasis.
Saha B; Tonkal AM; Croft S; Roy S
Clin Exp Immunol; 2004 Jul; 137(1):19-23. PubMed ID: 15196239
[TBL] [Abstract][Full Text] [Related]
26. Short report: requirement of b cells for delayed type hypersensitivity-like pathology after secondary infection with Leishmania major in resistant C57BL/6 mice.
DeKrey GK; Jones JJ; Mbow ML; Brodskyn CI; Titus RG
Am J Trop Med Hyg; 2003 Nov; 69(5):481-3. PubMed ID: 14695084
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major.
Ehrchen J; Helming L; Varga G; Pasche B; Loser K; Gunzer M; Sunderkötter C; Sorg C; Roth J; Lengeling A
FASEB J; 2007 Oct; 21(12):3208-18. PubMed ID: 17551101
[TBL] [Abstract][Full Text] [Related]
28. Splenectomy does not interfere with immune response to Leishmania major infection in mice.
Maioli TU; Carneiro CM; Assis FA; Faria AM
Cell Immunol; 2007 Sep; 249(1):1-7. PubMed ID: 18093575
[TBL] [Abstract][Full Text] [Related]
29. The influence of glutathione modulators on the course of Leishmania major infection in susceptible and resistant mice.
Cruz KK; Fonseca SG; Monteiro MC; Silva OS; Andrade VM; Cunha FQ; Romão PR
Parasite Immunol; 2008 Mar; 30(3):171-4. PubMed ID: 18251971
[TBL] [Abstract][Full Text] [Related]
30. Development of protective immunity against cutaneous leishmaniasis is dependent on STAT1-mediated IFN signaling pathway.
Rosas LE; Keiser T; Pyles R; Durbin J; Satoskar AR
Eur J Immunol; 2003 Jul; 33(7):1799-805. PubMed ID: 12811839
[TBL] [Abstract][Full Text] [Related]
31. In experimental leishmaniasis deficiency of CD18 results in parasite dissemination associated with altered macrophage functions and incomplete Th1 cell response.
Schönlau F; Scharffetter-Kochanek K; Grabbe S; Pietz B; Sorg C; Sunderkötter C
Eur J Immunol; 2000 Sep; 30(9):2729-40. PubMed ID: 11009109
[TBL] [Abstract][Full Text] [Related]
32. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection.
Arinola OG; Louis JS; Tacchini-Cottier F; Aseffa A; Salimonu LS
Afr J Med Med Sci; 2005 Mar; 34(1):65-70. PubMed ID: 15971557
[TBL] [Abstract][Full Text] [Related]
33. Protection of susceptible BALB/c mice from challenge with Leishmania major by nucleoside hydrolase, a soluble exo-antigen of Leishmania.
Al-Wabel MA; Tonui WK; Cui L; Martin SK; Titus RG
Am J Trop Med Hyg; 2007 Dec; 77(6):1060-5. PubMed ID: 18165522
[TBL] [Abstract][Full Text] [Related]
34. T cells that react to the immunodominant Leishmania major LACK antigen prevent early dissemination of the parasite in susceptible BALB/c mice.
Schilling S; Glaichenhaus N
Infect Immun; 2001 Feb; 69(2):1212-4. PubMed ID: 11160025
[TBL] [Abstract][Full Text] [Related]
35. Chronic antigen ingestion protects ovalbumin sensitized mice from severe manifestation of Leishmania major infection.
Saldanha JC; Gargiulo DL; Dourado LP; Santiago HC; Menezes GB; Reis ML; Tafuri WL; Teixeira MM; Vieira LQ; Cara DC
Parasite Immunol; 2008; 30(11-12):646-9. PubMed ID: 19067847
[TBL] [Abstract][Full Text] [Related]
36. Organ-specific and stage-dependent control of Leishmania major infection by inducible nitric oxide synthase and phagocyte NADPH oxidase.
Blos M; Schleicher U; Soares Rocha FJ; Meissner U; Röllinghoff M; Bogdan C
Eur J Immunol; 2003 May; 33(5):1224-34. PubMed ID: 12731047
[TBL] [Abstract][Full Text] [Related]
37. Decreased IL-10 and IL-13 production and increased CD44hi T cell recruitment contribute to Leishmania major immunity induced by non-persistent parasites.
Kedzierski L; Curtis JM; Doherty PC; Handman E; Kedzierska K
Eur J Immunol; 2008 Nov; 38(11):3090-100. PubMed ID: 18924210
[TBL] [Abstract][Full Text] [Related]
38. Leishmania-derived murine monocyte chemoattractant protein 1 enhances the recruitment of a restrictive population of CC chemokine receptor 2-positive macrophages.
Conrad SM; Strauss-Ayali D; Field AE; Mack M; Mosser DM
Infect Immun; 2007 Feb; 75(2):653-65. PubMed ID: 17088347
[TBL] [Abstract][Full Text] [Related]
39. IL-1-induced inflammation promotes development of leishmaniasis in susceptible BALB/c mice.
Voronov E; Dotan S; Gayvoronsky L; White RM; Cohen I; Krelin Y; Benchetrit F; Elkabets M; Huszar M; El-On J; Apte RN
Int Immunol; 2010 Apr; 22(4):245-57. PubMed ID: 20181656
[TBL] [Abstract][Full Text] [Related]
40. Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice.
Sacks D; Anderson C
Immunol Rev; 2004 Oct; 201():225-38. PubMed ID: 15361244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]